Marinus Pharmaceuticals SG&A Expense (Quarterly) Insights

Marinus Pharmaceuticals Inc (MRNS)

1.30 -0.03 (-2.26%) USD | NASDAQ | May 16, 16:00

1.31 +0.01 (+0.77%) After-Hours: 06:29

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	18.63M
December 31, 2023	15.36M
September 30, 2023	14.87M
June 30, 2023	15.72M
March 31, 2023	15.20M
December 31, 2022	14.66M
September 30, 2022	13.39M
June 30, 2022	17.06M
March 31, 2022	11.74M
December 31, 2021	10.62M
September 30, 2021	9.452M
June 30, 2021	6.828M
March 31, 2021	10.38M
December 31, 2020	6.006M
September 30, 2020	4.564M
June 30, 2020	4.13M
March 31, 2020	3.85M
December 31, 2019	2.96M
September 30, 2019	2.327M
June 30, 2019	2.502M
March 31, 2019	3.667M
December 31, 2018	2.186M
September 30, 2018	2.073M

Date	Value
June 30, 2018	2.338M
March 31, 2018	2.187M
December 31, 2017	1.593M
September 30, 2017	1.571M
June 30, 2017	1.691M
March 31, 2017	1.812M
December 31, 2016	1.518M
September 30, 2016	1.529M
June 30, 2016	1.586M
March 31, 2016	1.604M
December 31, 2015	1.442M
September 30, 2015	1.378M
June 30, 2015	1.255M
March 31, 2015	1.447M
December 31, 2014	1.403M
September 30, 2014	0.868M
June 30, 2014	0.458M
March 31, 2014	0.516M
December 31, 2013	0.3598M
September 30, 2013	0.3134M
June 30, 2013	0.3139M
March 31, 2013	0.1801M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.327M

Minimum

Sep 2019

18.63M

Maximum

Mar 2024

10.01M

Average

10.50M

Median

SG&A Expense (Quarterly) Benchmarks